Cargando…

Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease

In the present study, various procedures have been compared for the determination of lipophilicity, hydrophobicity, and plasma protein binding of curcuminoids, boswellic acids, andrographolides, and piperine as biologically active ingredients of botanicals used in IBD treatment. Our results have sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeličić, Mario-Livio, Amidžić Klarić, Daniela, Kovačić, Jelena, Verbanac, Donatella, Mornar, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413514/
https://www.ncbi.nlm.nih.gov/pubmed/36015114
http://dx.doi.org/10.3390/ph15080965
_version_ 1784775770289209344
author Jeličić, Mario-Livio
Amidžić Klarić, Daniela
Kovačić, Jelena
Verbanac, Donatella
Mornar, Ana
author_facet Jeličić, Mario-Livio
Amidžić Klarić, Daniela
Kovačić, Jelena
Verbanac, Donatella
Mornar, Ana
author_sort Jeličić, Mario-Livio
collection PubMed
description In the present study, various procedures have been compared for the determination of lipophilicity, hydrophobicity, and plasma protein binding of curcuminoids, boswellic acids, andrographolides, and piperine as biologically active ingredients of botanicals used in IBD treatment. Our results have shown that IAM-HPLC assay is the most suitable one for lipophilicity determination of all analytes regardless of their class and botanical source. HSA-HPAC and AGP-HPAC assays revealed that all investigated compounds have a higher affinity for HSA which is the most abundant protein in human plasma. The high affinity of biologically active compounds to all biological structures (phospholipids and proteins) admonishes that their small portion is available for therapeutic effects in IBD patients. Our experimental research is complemented by various theoretical approaches based on different algorithms for pharmacokinetic properties prediction. The similarities between experimental and calculated values were evaluated using PCA and CA as a statistical tool. The statistical analysis implies that plasma protein binding is a complex process, and theoretical approaches still cannot fully replace experimental ones.
format Online
Article
Text
id pubmed-9413514
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94135142022-08-27 Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease Jeličić, Mario-Livio Amidžić Klarić, Daniela Kovačić, Jelena Verbanac, Donatella Mornar, Ana Pharmaceuticals (Basel) Article In the present study, various procedures have been compared for the determination of lipophilicity, hydrophobicity, and plasma protein binding of curcuminoids, boswellic acids, andrographolides, and piperine as biologically active ingredients of botanicals used in IBD treatment. Our results have shown that IAM-HPLC assay is the most suitable one for lipophilicity determination of all analytes regardless of their class and botanical source. HSA-HPAC and AGP-HPAC assays revealed that all investigated compounds have a higher affinity for HSA which is the most abundant protein in human plasma. The high affinity of biologically active compounds to all biological structures (phospholipids and proteins) admonishes that their small portion is available for therapeutic effects in IBD patients. Our experimental research is complemented by various theoretical approaches based on different algorithms for pharmacokinetic properties prediction. The similarities between experimental and calculated values were evaluated using PCA and CA as a statistical tool. The statistical analysis implies that plasma protein binding is a complex process, and theoretical approaches still cannot fully replace experimental ones. MDPI 2022-08-04 /pmc/articles/PMC9413514/ /pubmed/36015114 http://dx.doi.org/10.3390/ph15080965 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jeličić, Mario-Livio
Amidžić Klarić, Daniela
Kovačić, Jelena
Verbanac, Donatella
Mornar, Ana
Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
title Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
title_full Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
title_fullStr Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
title_full_unstemmed Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
title_short Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
title_sort accessing lipophilicity and biomimetic chromatography profile of biologically active ingredients of botanicals used in the treatment of inflammatory bowel disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413514/
https://www.ncbi.nlm.nih.gov/pubmed/36015114
http://dx.doi.org/10.3390/ph15080965
work_keys_str_mv AT jelicicmariolivio accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease
AT amidzicklaricdaniela accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease
AT kovacicjelena accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease
AT verbanacdonatella accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease
AT mornarana accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease